Precipitation of a monoclonal antibody by soluble tungsten
about
Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational ModificationsMonoclonal antibody interactions with micro- and nanoparticles: adsorption, aggregation, and accelerated stress studiesPractical fundamentals of glass, rubber, and plastic sterile packaging systems.Effects of shear on proteins in solution.Biosimilar recombinant human erythropoietins ("epoetins") and future erythropoiesis-stimulating treatments.Differentiating factors between erythropoiesis-stimulating agents: an update to selection for anaemia of chronic kidney disease.Biopharmaceutical formulations for pre-filled delivery devices.Pre-filled syringes: a review of the history, manufacturing and challenges.Mouse Models for Assessing Protein Immunogenicity: Lessons and Challenges.Tungsten-induced denaturation and aggregation of epoetin alfa during primary packaging as a cause of immunogenicity.Development of biotechnology products in pre-filled syringes: technical considerations and approaches.Control of protein particle formation during ultrafiltration/diafiltration through interfacial protection.Biotherapeutic formulation factors affecting metal leachables from stainless steel studied by design of experiments.Biologics formulation factors affecting metal leachables from stainless steel.Chemical modifications in therapeutic protein aggregates generated under different stress conditions.Fluorogenic tagging methodology applied to characterize oxidized tyrosine and phenylalanine in an immunoglobulin monoclonal antibody.Use of CE-SDS gel for characterization of monoclonal antibody hinge region clipping due to copper and high pH stress.The importance of handling high-value biologicals: Physico-chemical instability and immunogenicity of monoclonal antibodies.
P2860
Q26738810-AB6275FE-A1E6-4BD1-8A24-77B94056EEFBQ37358993-64C25D8F-13F7-485A-9908-7B95A7930ED3Q37678408-2CEF449C-EF58-4595-90B3-87FE069F498FQ37810518-9CA96E6B-827E-496D-BC3E-44D261903553Q37999380-6C611295-8039-433B-B633-EA312570D2FDQ38075798-2A2E2F29-FBFE-4EA8-9AA7-E0914F0BAA38Q38090687-B5FA0E11-9CBA-4B1C-A9F6-4E653A693836Q38318706-23DCC349-D279-4C86-8523-87392DA6C6D8Q38798188-8BBD195E-BE9D-4610-BBA9-EC7E2CC66E1CQ41944133-45ECA820-6FF6-4272-B5F2-48CA70E0D28CQ41983098-4A8B5ACE-E082-4A7D-830F-63CDAA1529ACQ42009419-57CB88CC-987C-4611-ACAC-EEF76D080D53Q42588809-AAE0E061-10D2-4B20-8BA9-69EA91A26892Q42705671-D058843A-55A8-436B-B1D8-C37EA3774337Q42813806-208653BC-7BB2-4F7F-A6B3-3736DD096ACEQ44879644-BF14B360-BA03-4B6B-8C41-501AAE908D7AQ45853019-6ECC0934-F724-4E46-AE5B-E219AEC181EFQ53700837-33DD3FF0-2290-4E75-AAC0-8CBCD88DD877
P2860
Precipitation of a monoclonal antibody by soluble tungsten
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Precipitation of a monoclonal antibody by soluble tungsten
@en
Precipitation of a monoclonal antibody by soluble tungsten.
@nl
type
label
Precipitation of a monoclonal antibody by soluble tungsten
@en
Precipitation of a monoclonal antibody by soluble tungsten.
@nl
prefLabel
Precipitation of a monoclonal antibody by soluble tungsten
@en
Precipitation of a monoclonal antibody by soluble tungsten.
@nl
P2093
P2860
P356
P1476
Precipitation of a monoclonal antibody by soluble tungsten
@en
P2093
Erwin Freund
Jared S Bee
John F Carpenter
Stephanie A Nelson
P2860
P304
P356
10.1002/JPS.21707
P407
P577
2009-09-01T00:00:00Z